Track topics on Twitter Track topics that are important to you
EpiCast Report: Type 2 Diabetes Epidemiology Forecast to 2026
Type 2 diabetes T2D, formerly known as noninsulin dependent diabetes mellitus or adultonset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the body's inability to make use of available insulin along with relative insulin deficiency. T2D constitutes approximately 9095% of all diabetes cases around the world, while type 1 diabetes and gestational diabetes make up the remaining 510% of cases. Lifestyle factors such as obesity, physical inactivity, and dietary habits are modifiable risk factors, and can therefore be controlled or prevented. Nonmodifiable risk factors such as race/ethnicity, family history, and advancing age can also put a person at high risk for developing the disease. T2D is also associated with several comorbidities including chronic kidney disease, cardiovascular disease, hypertension, and dyslipidemia.
In the 7MM, GlobalData epidemiologists forecast an increase in the diagnosed prevalent cases of T2D from 56,060,328 diagnosed prevalent cases in 2016 to 77,823,223 diagnosed prevalent cases in 2026, with an annual growth rate AGR of 3.88% during the forecast period. The US will have the highest number of diagnosed prevalent cases of T2D among the 7MM throughout the forecast period, while Italy will have the lowest.
GlobalData's epidemiological forecast for the diagnosed prevalence of T2D in the 7MM is supported by longitudinal historical data, which provide detailed insights into the epidemiology of the disease in each market, from studies conducted in these respective countries. GlobalData epidemiologists used nationally representative, countryspecific studies published in peerreviewed journals or national healthcare databases to forecast the prevalent cases of diagnosed T2D in all of the 7MM. GlobalData epidemiologists also segment the diagnosed prevalent cases of T2D in each country by age and sex, and into the major comorbidities of T2D.
The Type 2 Diabetes T2D EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of T2D in the 7MM US, France, Germany, Italy, Spain, UK, and Japan. It includes a 10year epidemiological forecast for the diagnosed prevalent cases of T2D segmented by age for ages 20 years and older and sex in these markets. Additionally, the report provides a forecast of the major comorbidities of T2D, such as chronic kidney disease, cardiovascular disease, obesity, hypertension, and dyslipidemia in the diagnosed T2D prevalent pool.
The T2D epidemiology report is written and developed by Masters and PhDlevel epidemiologists.
The EpiCast Report is indepth, high quality, transparent and marketdriven, providing expert analysis of disease trends in the 7MM.
Reasons to buy
The T2D EpiCast report will allow you to
Develop business strategies by understanding the trends shaping and driving the global T2D market.
Quantify patient populations in the global T2D market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for T2D therapeutics in each of the markets covered.
Identify the percentage of T2D diagnosed prevalent cases by age, sex, and major comorbid disorders.
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...